Teva
About
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day.
Key facts
- Website
- tevapharm.com
- Type
- Company
- Headquarters
- Israel
- Portfolio companies
- 1
- Stages
- Series C
- Cheque size
- $3M to $3M
- Sector focus
- Life Sciences
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 12 Mar 2003 | Gamida Cell | Series C | $3M |
Add first review
Frequently asked
What companies has Teva invested in?
Teva has invested in Gamida Cell.